Chemical Structure (Alendronate 70 mg For Teva 1)
Alendronate Sodium
Product Images NDC 33261-820
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Alendronate Sodium (NDC 33261-820). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image Label (Alendronate 70 mg For Teva 10)
This is a cautionary note indicating that dispensing this medicine without prescription is prohibited under federal law, and it should be kept out of reach of children. The medicine, Alendronate 70mg, is available in a pack containing 20 pills and the recommended storage temperature is between 15-30℃ (56.36℉). The medicine is made by Aidarex Pharmaceuticals LLC and also known by its generic name, Fosamax, and the active ingredient is Sodium. The recommended dosage and frequency are not provided in readable text. The manufacturing company is Teva Pharmaceuticals USA, and the location is Sellersville, PA 18960.*
Figure 1 (Alendronate 70 mg For Teva 2)
Figure 2 (Alendronate 70 mg For Teva 3)
Figure 3 (Alendronate 70 mg For Teva 4)
This appears to be a graph or chart displaying a study of Alendronate Sodium 10 mg over the course of 36 months, with time measured in months on the x-axis and numbers on the y-axis ranging from 0 to 10. However, without more information or context, it is difficult to say anything more specific about the study or its results.*
Figure 3a (Alendronate 70 mg For Teva 5)
This is not-available as the text is incomplete and doesn't provide enough information.*
Figure 4 (Alendronate 70 mg For Teva 6)
The text provides a table showing the mean percentage change and standard error of BMD (bone mineral density) for two-year study participants taking either alendronate sodium 5 mo/day or a placebo. The table displays the changes in BMD from baseline at different bone sites, including Femoral Trochanter, Neck, and Total Body.*
Figure 4a (Alendronate 70 mg For Teva 7)
Figure 5 (Alendronate 70 mg For Teva 8)
The text provides a comparison of the percent change in bone mineral density (BMD) at different sites of the body for individuals taking alendronate sodium 5 mg/day versus a placebo over a 2-year study period. The BMD change from the baseline is measured at three sites: femoral neck, trochanter, and total body. However, there are no specific percentages or measurements given to determine the extent of the change.*
Figure 6 (Alendronate 70 mg For Teva 9)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
